-
Ganoderma Polysaccharide Enhances mRNA-LNP Efficacy
2026-08-17
A 2026 Pharmaceutics study identifies Ganoderma lucidum polysaccharide as an adjunct that may improve mRNA-LNP performance by reducing oxidative stress and modulating innate cellular responses. The formulation increased reporter protein expression in vitro and in vivo, while its translational relevance depends on further optimization, mechanistic validation, and testing across mRNA cargos and delivery contexts.
-
Sulfamonomethoxine Toxicity Across Aquatic Trophic Levels
2026-08-17
Huang and colleagues evaluated sulfamonomethoxine toxicity across algae, cladocerans, and medaka to compare acute and chronic sensitivity at multiple aquatic trophic levels. Their results identify microalgae as particularly sensitive test organisms and show why antibiotic residues from aquaculture require species-specific ecological assessment rather than reliance on a single indicator species.
-
PR-619: Practical DUB Inhibition Workflows
2026-08-16
PR-619 is a cell-permeable, reversible deubiquitylating enzymes inhibitor for mapping ubiquitinated-protein accumulation without directly blocking proteasomal catalytic activity. This guide translates its chemistry into reproducible workflows for ubiquitination pathway research, autophagy assays, cancer biology, and neurodegenerative disease models.
-
Clodronate Liposomes for Macrophage Studies
2026-08-15
Clodronate Liposomes provide a route-flexible way to test whether macrophages drive a phenotype in vivo, rather than merely correlating with it. This guide combines depletion controls, tissue-specific verification, and aging-focused phagocytosis assays to improve mechanistic interpretation and reproducibility.
-
FLAG tag Peptide: From Tag to Assay Logic
2026-08-14
The FLAG tag Peptide (DYKDDDDK) enables selective recombinant protein detection and gentle affinity purification. This article connects its assay chemistry to recent Smg5–Hnrnpl–Mag findings and shows how to design protein-level experiments that do not confuse transcript abundance with molecular function.
-
Cy5.5 NHS Ester: Labeling for In Vivo Imaging
2026-08-14
Cy5.5 NHS ester converts amino-bearing proteins, peptides, oligonucleotides, and delivery materials into trackable near-infrared probes. This practical guide connects amine-labeling chemistry with nanoparticle and hydrogel studies, emphasizing formulation control, purification, imaging controls, and troubleshooting for reproducible in vivo fluorescence imaging.
-
URB597 (KDS-4103) Workflow for FAAH Studies
2026-08-13
URB597 enables direct, selective FAAH inhibition for separating anandamide biology from broader cannabinoid-drug effects. This practical workflow connects target engagement, pain-related behavior, LC-MS/MS, and neuroinflammation readouts for more interpretable endocannabinoid experiments.
-
Taltirelin Acetate: From Receptor to Readout
2026-08-13
Taltirelin acetate links selective TRH receptor pharmacology with sustained motor and neuroprotective readouts. This guide interprets the key OSA study and translates its findings into better assay design across neuroscience, Parkinson’s disease, itch, and formulation research.
-
Targeted mRNA Delivery to Islet β Cells
2026-08-12
Enriquez and colleagues developed eGLP-1-conjugated lipid nanoparticles that enrich mRNA delivery to pancreatic β cells and demonstrated functional delivery in mouse, human, and xenotransplant models. Delivery of PD-L1 mRNA reduced insulitis and delayed autoimmune diabetes in NOD mice, while the platform also highlights the remaining translational and targeting limitations of β cell-directed RNA therapeutics.
-
Rhodamine 123: Designing Better Transport Assays
2026-08-12
Rhodamine 123 (chloride) enables live-cell analysis of uptake and P-glycoprotein-mediated efflux. This guide shows how to separate transporter effects from dye chemistry, cell-specific sequestration, and ABCG2-related drug-resistance biology.
-
Antimycin A4: ATP-Citrate Lyase Workflow
2026-08-11
Antimycin A4 combines ATP-citrate lyase inhibition with mitochondrial respiratory-chain activity, making it useful for separating lipid-biosynthesis effects from broader energy-metabolism phenotypes. This practical guide covers assay setup, staged validation, controls, and troubleshooting for biochemical and cellular studies.
-
ARCA Cy5 EGFP mRNA (5-moUTP) Guide
2026-08-11
Use ARCA Cy5 EGFP mRNA (5-moUTP) to separate cellular uptake from productive translation in mammalian delivery experiments. Its covalent Cy5 label and EGFP reporter support microscopy, flow cytometry, formulation screening, and troubleshooting in a single workflow.
-
Puromycin Aminonucleoside for Podocyte Injury
2026-08-10
Puromycin aminonucleoside is the aminonucleoside moiety of puromycin and a nephrotoxic agent used to model proteinuria, podocyte injury, and glomerular pathology. Its reported effects include foot-process disruption, rat glomerular lesions resembling FSGS, transporter-sensitive cytotoxicity, and pH-dependent cellular uptake.
-
ARCA Cy5 EGFP mRNA (5-moUTP) Workflow
2026-08-09
Build a dual-readout mRNA localization and translation efficiency assay with one fluorescent reporter: Cy5 tracks delivery, while EGFP reports productive translation. This workflow connects practical mammalian-cell transfection optimization with the targeted nanoparticle strategy reported in a 2024 ACS Nano study.
-
Obeticholic Acid for FXR Liver Models
2026-08-08
Obeticholic Acid provides a receptor-proximal way to interrogate bile acid regulation, fibrosis, and hepatic inflammation. This workflow pairs FXR gene readouts with histology, biochemical endpoints, and the immune-resolution framework highlighted in recent fibrosis research.